Video

Global probiotic supplements in 2024: A $9.4B market, China’s surge, Europe’s e-commerce paradox, and fragmented regulation

Microbiomepost conducted an exclusive interview with George Paraskevakos, Executive Director at International Probiotic Association in order to discuss the global market of biotic products in 2025.

Why probiotic health claims rarely succeed at EFSA: evidence standards, study populations, and the challenge of live microorganisms

Ger T. Rijkers, University College Roosevelt, Netherlands, discusses the regulatory frame about probiotics in Europe.

Probiotics and public health: small interventions, billion-Euro stakes

Mike Holland, who has spent decades valuing the health and economic impacts of policy choices for the European Commission, the European Environment Agency and the OECD, discusses the economic impact…

Enteric pathogens as active drivers of dysbiosis: lessons from Bacillus cereus and experimental models of the gut microbiota

Emilia Ghelardi, Professor of Microbiology and Molecular Microbiology at the University of Pisa, explains how pathogens can actively disrupt the integrity of the commensal community.

Reinforcing the gut barrier: how probiotics support intestinal integrity and immune health

Arthur Ouwehand, Technical Fellow at IFF Finland, discusses the components and vulnerabilities of the gut barrier and reviews how probiotics and related dietary interventions can support its structure and function.

Bifidobacterium longum subsp. infantis M-63: shaping early-life gut microbiota and immunity in healthy full-term infants

Akari Hiraku, researcher at Innovative Research Institute, Morinaga Milk Industry Co., presented clinical data on Bifidobacterium longum subsp. infantis M-63, a probiotic strain with a remarkable capacity to utilize HMOs.

Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer

Philippe Langella, Research director at INRAE, talks about how F. prausnitzii could be a beneficial commensal.

Microbiota, immunity, and the environment: towards an integrated One Health approach

At the 13th Probiotics, Prebiotics and New Foods Congress, Silvia Turroni (University of Bologna) shares insights from the session “The Microbiome and One Health,” which explored how the microbiota bridges…

Microbiota and women’s health: emerging evidence and personalized perspectives

During the 2025 Probiotics, Prebiotics & New Food congress, it was presented the English edition of "Microbioma al femminile", a book dedicated to the intricate relationship between the microbiota and…

Innovating with probiotics: the case of Limosilactobacillus reuteri and the Black Queen hypothesis in strain discovery

Gianfranco Grompone, scientific director at BioGaia, explored innovative strategies for developing next-generation probiotics, with a focus on Limosilactobacillus reuteri DSM 17938. 

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top